Icade Valuation

Is 0K4O undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0K4O when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0K4O (€22.18) is trading above our estimate of fair value (€17.86)

Significantly Below Fair Value: 0K4O is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0K4O?

Key metric: As 0K4O is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 0K4O. This is calculated by dividing 0K4O's market cap by their current revenue.
What is 0K4O's PS Ratio?
PS Ratio1.1x
Sales€1.52b
Market Cap€1.69b

Price to Sales Ratio vs Peers

How does 0K4O's PS Ratio compare to its peers?

The above table shows the PS ratio for 0K4O vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average13x
UKCM UK Commercial Property REIT
13xn/aUK£947.3m
BCPT Balanced Commercial Property Trust
12.1x1.3%UK£672.1m
LMP LondonMetric Property
21.3x15.3%UK£3.8b
BLND British Land
5.6x-2.7%UK£3.7b
0K4O Icade
1.1x4.8%€1.7b

Price-To-Sales vs Peers: 0K4O is good value based on its Price-To-Sales Ratio (1.1x) compared to the peer average (13x).


Price to Sales Ratio vs Industry

How does 0K4O's PS Ratio compare vs other companies in the GB REITs Industry?

0 CompaniesPrice / SalesEstimated GrowthMarket Cap
No more companies available in this PS range
0K4O 1.1xIndustry Avg. 8.2xNo. of Companies4PS048121620+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 0K4O is good value based on its Price-To-Sales Ratio (1.1x) compared to the European REITs industry average (8.2x).


Price to Sales Ratio vs Fair Ratio

What is 0K4O's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0K4O PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.1x
Fair PS Ratio4x

Price-To-Sales vs Fair Ratio: 0K4O is good value based on its Price-To-Sales Ratio (1.1x) compared to the estimated Fair Price-To-Sales Ratio (4x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0K4O forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€22.18
€31.04
+40.0%
18.1%€40.50€23.00n/a12
Nov ’25€23.94
€30.88
+29.0%
18.8%€40.50€23.00n/a12
Oct ’25€26.57
€30.32
+14.1%
19.8%€40.50€23.00n/a11
Sep ’25€20.43
€27.71
+35.6%
18.0%€37.00€22.80n/a11
Aug ’25€20.60
€28.35
+37.6%
16.9%€37.00€22.80n/a11
Jul ’25€23.50
€29.49
+25.5%
14.4%€37.00€22.80n/a11
Jun ’25€28.31
€29.36
+3.7%
14.6%€37.00€22.80n/a11
May ’25€25.14
€29.59
+17.7%
15.0%€37.00€22.80n/a10
Apr ’25€25.03
€32.89
+31.4%
23.5%€53.00€22.80n/a10
Mar ’25€27.92
€35.59
+27.5%
21.3%€53.00€22.80n/a12
Feb ’25€30.88
€37.22
+20.5%
19.4%€53.00€22.80n/a12
Jan ’25€35.92
€39.77
+10.7%
24.9%€53.00€22.80n/a10
Dec ’24€33.36
€39.98
+19.9%
23.9%€53.00€22.80n/a11
Nov ’24€31.08
€41.14
+32.4%
23.3%€53.00€21.30€23.9410
Oct ’24€31.29
€41.55
+32.8%
22.4%€53.00€21.30€26.5710
Sep ’24€34.59
€44.05
+27.4%
23.8%€58.00€21.30€20.4310
Aug ’24€36.76
€46.21
+25.7%
20.9%€58.00€21.30€20.6011
Jul ’24€38.26
€48.85
+27.7%
22.3%€61.00€21.30€23.5011
Jun ’24€37.49
€49.95
+33.2%
22.7%€66.00€21.30€28.3112
May ’24€42.30
€49.88
+17.9%
22.9%€66.00€21.30€25.1412
Apr ’24€43.14
€49.88
+15.6%
22.9%€66.00€21.30€25.0312
Mar ’24€46.84
€46.92
+0.2%
24.5%€66.00€21.30€27.9212
Feb ’24€43.78
€46.63
+6.5%
24.8%€66.00€21.30€30.8812
Jan ’24€40.57
€48.05
+18.4%
26.4%€66.00€21.30€35.9212
Dec ’23€39.63
€48.52
+22.4%
26.4%€66.00€21.30€33.3612
Nov ’23€38.61
€55.14
+42.8%
19.1%€71.00€32.50€31.0812

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies